Significant Ownership of Madison Avenue Partners, LP
-
Signature - Title
-
/s/ Eli Samaha - Eli Samaha, as Managing Member of EMAI Management, LLC, its General Partner
-
Location
-
New York, NY
-
Summary
-
This page shows a list of all the recent SCHEDULE 13D/G filings made by Madison Avenue Partners, LP.
Follow Filing Activity
Follow Madison Avenue Partners, LP and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Madison Avenue Partners, LP
| Sym |
Company |
Class |
Ownership |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
| AIV |
APARTMENT INVESTMENT & MANAGEMENT CO |
Class A Common Stock, no par value (the "Common Stock") |
8.6% |
$73,347,067 |
|
12,347,991 |
|
Madison Avenue International LP |
26 Feb 2026 |
| MDRX |
Veradigm Inc. |
Common Stock, par value $0.01 per share (the "Common Stock") |
6.6% |
$34,185,621 |
|
7,167,999 |
|
Madison Avenue International LP |
22 Jan 2026 |
| SLRN |
ACELYRIN, Inc. |
Common Stock |
5.1% |
$12,468,687 |
|
5,089,260 |
|
Madison Avenue Partners, LP |
29 Apr 2025 |
| INDV |
Indivior Pharmaceuticals, Inc. |
Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") |
5% |
$213,537,068 |
-$39,360,134 |
6,280,502 |
-16% |
Madison Avenue International LP |
31 Dec 2025 |
| MAGN |
Magnera Corporation |
Common Stock, $0.01 par value per share (the "Common Stock") |
5% |
$26,959,026 |
-$15,921,708 |
1,780,649 |
-37% |
Madison Avenue International LP |
31 Dec 2025 |
| WLY |
John Wiley & Sons, Inc. |
Class A Common Stock, par value $1.00 per share (the "Common Stock") |
5% |
$98,427,963 |
|
2,229,904 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| OVID |
Ovid Therapeutics Inc. |
Common Stock, par value $0.001 per share (the "Common Stock") |
4% |
$969,800 |
|
2,852,352 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| KROS |
Keros Therapeutics, Inc. |
Common Stock, $0.0001 par value per share (the "Common Stock") |
2.7% |
$16,062,286 |
-$34,918,552 |
823,707 |
-68% |
Madison Avenue International LP |
31 Dec 2025 |
| CRGX |
CARGO Therapeutics, Inc. |
Common stock, par value $0.001 per share (the "Common Stock") |
0% |
$0 |
-$18,745,508 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |
| SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share (the "Common Stock") |
0% |
$0 |
-$124,440,060 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |
Schedules 13D/G Reported by Madison Avenue Partners, LP:
| Sym |
Target |
Class |
Ownership |
Change |
Current Shares |
Change |
Value |
Reporting name |
Form |
Report Period |
Filing Date |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.